MedPath

Threat-Avoidance Learning in Anxiety Patients

Conditions
Stress Disorders, Traumatic
Panic Disorder
Phobic Disorders
Interventions
Behavioral: Avoidance experiment
Registration Number
NCT02336802
Lead Sponsor
KU Leuven
Brief Summary

Anxiety disorders are characterized by exaggerated levels of fear that are not proportional to the actual level of threat. More specifically, anxiety patients have marked deficits in the downregulation of fear reactions during situations of objective safety. Pre-clinical research on Pavlovian fear conditioning and extinction has discovered that fear downregulation stems from areas in the prefrontal cortex (the ventro-medial prefrontal cortex, vmPFC) that recruit intercalated cells in the amygdala to inhibit its central nucleus, which is responsible for a variety of behavioral expressions of fear (Milad \& Quirk, 2012). Accordingly, functional magnetic resonance imaging studies (fMRI) revealed reduced vmPFC activity coupled with increased fear reactions during situations of objective safety in anxiety patients (Milad et al., 2009). Another core symptom of anxiety disorders, though much less investigated, is the excessive avoidance of situations that trigger the fears. These 'safety behaviors' often interfere with daily life activities and valued goals in life, and they are thought to perpetuate the exaggerated levels of fear by precluding opportunities to learn that the feared situations are actually not dangerous. Surprisingly, experimental research on avoidance behaviors in anxiety patients is virtually non-existent. This experiment modifies the Pavlovian fear conditioning procedure to include avoidance, and explores the behavioral and neural processes of this type of fear regulation in anxiety patients (trans-diagnostically) and healthy individuals.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • 18-65 years of age. Proficient in English. Right-handed Free of medication that affect cerebral metabolism. Able to give informed consent. High stress level (defined as a score of >= 3 on the 4-item Perceived Stress Scale).
Exclusion Criteria

History of neurologic or psychiatric disease (other than the specified anxiety disorder), substance abuse or dependence that is current or within the last year.

Major/chronic medical conditions. History of head injury resulting in prolonged loss of consciousness and/or neurological sequelae. History of seizures. History of stroke Prior neurosurgical procedure. Metal in the body, metal injury to the eyes. Implanted pacemaker, medication pump, vagal stimulator, deep brain stimulator, TENS unit, or ventriculo-peritoneal shunt. Pregnancy; breastfeeding or nursing Claustrophobia Weight > 350 lbs.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
PTSD groupAvoidance experimentVolunteers that meet diagnostic criteria for Post-Traumatic Stress Disorder
Healthy Control GroupAvoidance experimentVolunteers that meet no diagnostic criteria for mental disorders.
Panic Disorder GroupAvoidance experimentVolunteers that meet diagnostic criteria for Panic Disorder.
Phobic Disorder GroupAvoidance experimentVolunteers that meet diagnostic criteria for a Phobic Disorder.
Primary Outcome Measures
NameTimeMethod
functional magnetic resonance imaging1.5 hours

We will measure functional MRI during fear conditioning, avoidance and generalization. Furthermore, we will measure changes in structural MRI data, Diffusion Tensor Imaging (DTI) data and resting state fMRI data.

Secondary Outcome Measures
NameTimeMethod
Skin conductance reactivity1.5 hours

fluctuations in skin conductance will be measured alongside MRI data collection, as a peripheral physiological measure of fear.

Questionnaires2 hours

In a separate sessions, participants will fill out a variety of personality questionnaires probing levels of anxiety and avoidance tendency.

Trial Locations

Locations (1)

University of KU Leuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath